Brain region-specific changes in the expression of calcium sensor proteins after repeated applications of ketamine to rats

Neuroscience Letters

Volumn 339, Issue 2, 2003, Pages 95-98

  Bernstein, Hans Gert ^a   Becker, Axel ^a   Keilhoff, Gerburg ^a   Spilker, Christina ^b   Gorczyca, Wojiech A ^b   Braunewell, Karl Heinz ^b   Grecksch, Gisela ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Hippocalcin; Immunohistochemistry; Ketamine; Repeated application; Schizophrenia relevant changes; Visinin like protein 1; Visinin like protein 3

Indexed keywords

CALCIUM; HIPPOCALCIN; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN; UNCLASSIFIED DRUG; VISININ; VISININ LIKE PROTEIN 1; VISININ LIKE PROTEIN 3;

ANIMAL CELL; ARTICLE; BRAIN REGION; CELLULAR DISTRIBUTION; CINGULATE GYRUS; CONTROLLED STUDY; IMMUNOREACTIVITY; INTERNEURON; MALE; NERVE CELL; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; SUBICULUM;

EID: 0037457405     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)01482-9     Document Type: Article

References (23)

1. Becker A., Schröder H., Mann T., Hüther G., Grecksch G. Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Int. J. Neuropsychopharmacol. 5:2002;S61.
2. Bernstein H.-G., Keilhoff G., Seidel B., Stanarius A., Huang P.L., Fishman M.C., Reiser M., Bogerts B., Wolf G. Expression of hypothalamic peptides in mice lacking neuronal nitric oxide synthase: reduced β-END immunoreactivity in the arcuate nucleus. Neuroendocrinology. 68:1998;403-411.
3. Bernstein H.-G., Baumann B., Danos P., Diekmann S., Bogerts B., Gundelfinger E.D., Braunewell K.-H. Regional and cellular distribution of neural visinin-like protein immunoreactivities in human brain. J. Neurocytol. 28:1999;655-662.
4. Bernstein H.-G., Braunewell K.-H., Spilker C., Danos P., Baumann B., Funke S., Diekmann S., Gundelfinger E.D., Bogerts B. Hippocampal expression of the calcium sensor protein visinin-like protein-1 in schizophrenia. NeuroReport. 13:2002;393-396.
5. Braunewell K.-H., Brackmann M., Schaupp M., Spilker C., Anand R., Gundelfinger E.D. Intracellular neuronal calcium sensor (NCS) VILIP-1 modulates cGMP signalling pathways in transfected neural cells and cerebellar granule neurones. J. Neurochem. 78:2001;1277-1286.
6. Braunewell K.-H., Riederer P., Spilker C., Gundelfinger E.D., Bogerts B., Bernstein H.-G. Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (VILIPs)-1 and -3, in neocortical brain areas of Alzheimer disease patients. Dement. Geriatr. Cogn. Disord. 12:2001;110-116.
7. Furuta Y., Kobayashi M., Masaki T., Takamatsu K. Age-related changes in expression of hippocalcin and NVP2 in rat brain. Neurochem. Res. 24:1999;651-658.
8. Hamamashi H., Tamaru T., Nogushi H., Kobayashi M., Takamatsu K. Immuno-chemical assessment of neural visinin-like calcium-binding protein 3 in rat brain. Neurosci. Res. 39:2001;133-149.
9. Kajimoto Y., Shirakawa O., Kuno T., Nishino N., Nakai H. Delayed changes in neural protein gene expression caused by acute phencyclidine administration. J. Neural Transm. Gen. Sect. 100:1995;257-262.
10. 2 receptors - implications for models of schizophrenia. Mol. Psychiatry. 2002;7837-7844.
11. Kim S.H., Price M.T., Olney J.W., Farber N.B. Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and α2-adrenergic agonistts. Mol. Psychiatry. 4:1999;344-352.
12. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Henninger G.R., Bowers M.B. Jr, Charney D.S. Subanesthetic effects of the noncompetitive NMDA receptor antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine repsonses. Arch. Gen. Psychiatry. 51:1994;199-241.
13. Lahti A.C., Koffel B., LaPorte D., Tamminga C.A. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology. 13:1995;9-19.
14. Lindefors N., Barati S., O'Connor W.T. Differential effects of single and repeated ketamine administration on dopamine, serotonin, and GABA transmission in rat medial prefrontal cortex. Brain Res. 759:1997;205-212.
15. Nelson C.L., Burk J.A., Bruno J.P., Sarter M. Effects of acute and repeated systemic administration of ketamine on prefrontal acetylcholine release and sustained attention performance in rats. Psychopharmacology. 161:2002;168-179.
16. Newcomer J.W., Farber N.B., Jevtovic-Todorovic V., Selke G., Melson A.K., Hershey T., Craft S., Olney J.W. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology. 20:1999;106-118.
17. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry. 52:1995;998-1007.
18. Oranje B., van Berckel B.N.M., Kemner C., van Ree J.M., Kahn R.S., Verbaten M.N. The effects of a sub-anesthetic dose of ketamine on human selective attention. Neuropsychopharmacology. 22:2000;293-302.
19. Paterlini M., Revilla V., Grant A.L., Wisden W. Expression of neuronal calcium sensor protein family in rat brain. Neuroscience. 99:2000;205-216.
20. Saitoh S., Takamatsu K., Kobayashi M., Noguchi T. Distribution of hippocalcin mRNA and immunoreactivity in rat brain. Neurosci. Lett. 157:1993;107-110.
21. Schröder U., Schröder H., Darius J., Grecksch G., Sabel B.A. Simulation of psychosis by continuous delivery of phencyclidine from controlled-release polymer implants. Behav. Brain Res. 97:1998;59-68.
22. Spilker C., Richter K., Smalla K.-H., Manahan-Vaughan D., Gundelfinger E.D., Braunewell K.-H. The neuronal EF-hand calcium-binding protein visinin-like protein-3 is expressed in cerebellar Purkinje cells and shows a calcium-dependent membrane association. Neuroscience. 96:2000;121-129.
23. Spilker C., Dresbach T., Braunewell K.-H. Reversible translocation and activity-dependent localization of the calcium-myristol switch protein VILIP-1 to different membrane compartments in living hippocampal neurons. J. Neurosci. 22:2002;7331-7339.